Skip to main content
. 2020 Jul 13;44(3):1037–1048. doi: 10.3892/or.2020.7686

Figure 3.

Figure 3.

OTSSP167 reduces tumorigenesis in vivo. (A) Tumor xenografts were significantly smaller in mice orally fed OTSSP167 compared with the control group. (B) Time-dependent reduction in the volume of the tumor xenografts in mice orally fed OTSSP167 daily. (C) Tumor volumes and (D) tumor weights were significantly lower in the mice fed OTSSP167 compared with the vehicle control. (E) Western blots revealing reduced MELK expression in the tumors of mice fed OTSSP167. **P<0.01, ***P<0.001. MELK, maternal embryonic leucine zipper kinase; p.o, per os; q.d. quaque die.